Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Lymphoma, Large B-Cell, Diffuse
and you are
between 18 and 60
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a randomized, multi-center,phase III study to evaluate the ability of thalidomide maintenance therapy to prolong relapse-free survival in diffuse large B cell lymphoma(DLBCL).

Provided treatments

  • Drug: Thalidomide
  • Other: Observation
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03016000. The sponsor of the trial is Nanfang Hospital of Southern Medical University and it is looking for 226 volunteers for the current phase.
Official trial title:
A Multicentre, Randomized Phase III Study of Thalidomide Maintenance Treatment in Patients With Diffuse Large B-cell Lymphoma